The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
392 - Would a corporate message similar to "Company X is committed to research in prostate cancer" be PAAB exempt?
-
On its own (not linked to anything else), this statement is a corporate message without product mention. It is therefore exempt under s1.5. Please keep in mind that Health Canada is very concerned about pre-NOC product messages (whether direct or implied). If you plan on including additional information, it is advisable to submit the piece for PAAB review with the aim of avoiding inadvertently creating materials that contravene C.08.002 of the Food and Drug Regulations.
